Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Cancer Research
|
April 1, 1979
A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia
D J Fernandes, P Klubes
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|
April 1, 1991
Nuclear matrix targets for anticancer agents
D J Fernandes, C V Catapano
Biochemical Pharmacology
|
January 1, 1985
Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities
D J Fernandes, S K Cranford
Biochemical Pharmacology
|
May 16, 2000
Topoisomerase II cleavable complex formation within DNA loop domains
J M Lambert, D J Fernandes
Biochemistry
|
April 10, 1990
Synthesis and distribution of primer RNA in nuclei of CCRF-CEM leukemia cells
M T Paff, D J Fernandes
International Review of Cytology
|
January 1, 1995
The nuclear matrix as a site of anticancer drug action
D J Fernandes, C V Catapano
Analytical Biochemistry
|
November 1, 1984
A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts
D J Fernandes, S K Cranford
Cancer Research
|
April 1, 1986
Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid
D J Fernandes, S K Cranford
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates
D J Fernandes, J R Bertino
Biochemistry
|
December 17, 1996
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity
J Qiu, C V Catapano, D J Fernandes
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Cancer Research
|
April 1, 1979
A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia
D J Fernandes, P Klubes
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|
April 1, 1991
Nuclear matrix targets for anticancer agents
D J Fernandes, C V Catapano
Biochemical Pharmacology
|
January 1, 1985
Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities
D J Fernandes, S K Cranford
Biochemical Pharmacology
|
May 16, 2000
Topoisomerase II cleavable complex formation within DNA loop domains
J M Lambert, D J Fernandes
Biochemistry
|
April 10, 1990
Synthesis and distribution of primer RNA in nuclei of CCRF-CEM leukemia cells
M T Paff, D J Fernandes
International Review of Cytology
|
January 1, 1995
The nuclear matrix as a site of anticancer drug action
D J Fernandes, C V Catapano
Analytical Biochemistry
|
November 1, 1984
A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts
D J Fernandes, S K Cranford
Cancer Research
|
April 1, 1986
Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid
D J Fernandes, S K Cranford
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates
D J Fernandes, J R Bertino
Biochemistry
|
December 17, 1996
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity
J Qiu, C V Catapano, D J Fernandes
Page
of 5